On October 17–18, members of our lab presented three talks at the European Association of Neuro-Oncology (EANO) Annual Meeting in Prague, including two selected for plenary sessions. These presentations highlighted recent findings from the PuMP and ETAPA clinical trials, as well as ongoing work from our tumor-infiltrating lymphocyte (TIL) program.
We are proud to see our teams work represented on an international stage and look forward to the discussions and collaborations that will follow.